ftInvstr

ORTINGLOBE · Healthcare ₹14.0 -0.78% Mkt Cap ₹11 Cr

ORTINGLOBE

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹14.0

-0.78% today · 30d -3.31%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for ORTINGLOBE. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-03-31

REVENUE

₹0 Cr

-24.06% YoY

NET PROFIT

₹0 Cr

OPM

-2.4%

+184.15pp YoY

EPS

₹-0.01

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-5.1% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

ORTINGLOBE——

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 90

Valuation — —

Growth DECLINING 24

Profitability LOW 5

Technicals WEAK 47

Risk LOW 90

Key Stats

P/B

10.5

52W HIGH

₹21.3

OFF HIGH

-34.27%

DIV YIELD

0.0%

MKT CAP

₹11 Cr

◉ Active Signals

MACDNeutral0.0925

RSI(14)Neutral49.59

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ORTINGLOBE and at what entry.